Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
0.50%66.8622.0%$201.05m
ZGNXZogenix, Inc.
1.67%39.6516.8%$134.04m
SHPGShire PLC Sponsored ADR
1.05%147.820.4%$131.58m
VRXValeant Pharmaceuticals International, Inc.
0.69%12.4814.2%$115.17m
PRGOPerrigo Co. Plc
-1.24%87.456.5%$92.40m
AERIAerie Pharmaceuticals, Inc.
0.62%64.858.6%$65.23m
MNKMallinckrodt Plc
2.05%32.8217.7%$56.91m
CTLTCatalent Inc
1.23%42.682.7%$56.83m
JAZZJazz Pharmaceuticals Plc
3.23%145.002.2%$54.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.58%109.407.6%$49.32m
UTHRUnited Therapeutics Corporation
-0.88%119.0614.4%$45.49m
ENDPEndo International Plc
3.01%7.888.9%$41.77m
PTLAPortola Pharmaceuticals, Inc.
0.36%50.477.9%$41.55m
HZNPHorizon Pharma plc
2.24%14.147.6%$35.30m
MDCOMedicines Company
-0.26%34.4522.1%$34.68m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.